RESUMO
Pretreatment with mGluR1 antagonist AIDA (1 mg/kg) nearly completely prevented the onset of tonic-clonic seizures and increased generation of NO in the cerebral cortex of rats with genetically determined audiogenic reaction to acoustic stimulation. Administration of mGluR5 antagonist MPEP (10 mg/kg) before audiogenic exposure was followed by a significant decrease in the degree of seizure and partially prevented increased generation of NO due to acoustic stimulation. These data indicate that mGlu receptors and NO play an important role in the pathogenetic mechanisms of audiogenic seizures.
Assuntos
Estimulação Acústica/efeitos adversos , Epilepsia Reflexa/prevenção & controle , Epilepsia Tônico-Clônica/prevenção & controle , Antagonistas de Aminoácidos Excitatórios/uso terapêutico , Indanos/uso terapêutico , Proteínas do Tecido Nervoso/antagonistas & inibidores , Óxido Nítrico/fisiologia , Piridinas/uso terapêutico , Receptor de Glutamato Metabotrópico 5/antagonistas & inibidores , Receptores de Glutamato Metabotrópico/antagonistas & inibidores , Animais , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Espectroscopia de Ressonância de Spin Eletrônica , Epilepsia Reflexa/etiologia , Epilepsia Reflexa/fisiopatologia , Epilepsia Tônico-Clônica/etiologia , Epilepsia Tônico-Clônica/fisiopatologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Indanos/farmacologia , Masculino , Proteínas do Tecido Nervoso/fisiologia , Óxido Nítrico/biossíntese , Piridinas/farmacologia , Ratos , Ratos Mutantes , Receptor de Glutamato Metabotrópico 5/fisiologia , Receptores de Glutamato Metabotrópico/fisiologiaRESUMO
The gas NO is a messenger that modulates neuronal function. The use of NO donors and NO synthase inhibitors as pharmacological tools revealed that this free radical is probably implicated in the regulation of excitability and firing, in long-term potentiation and long-term depression, as well as in memory processes. Moreover, NO modulates neurotransmitter release. In vivo and in vitro studies have shown that, in all brain structures investigated, endogenous NO modulates the release of several neurotransmitters, such as acetylcholine, catecholamines, excitatory and inhibitory amino acids, serotonin, histamine, and adenosine. In most cases, enhanced NO level in the tissue increases the release of neurotransmitters, although decreasing effects have also been observed. Cyclic 3'-5' guanosine monophosphate and glutamate mediate the modulation of transmitter release by NO. Recent observations suggest that the release of some transmitters is dually influenced by NO. Thus, besides modulation by presynaptically located auto- and heteroreceptors, NO released from nitrergic neurons seems to play a universal role in modulating the release of transmitters in the brain.
Assuntos
Química Encefálica/fisiologia , Neurônios/metabolismo , Neurotransmissores/metabolismo , Óxido Nítrico/metabolismo , Transmissão Sináptica/fisiologia , Animais , HumanosRESUMO
A 2- to 3-fold increase of GTP cyclohydrolase I (E.C. 3.5.4.16), the key enzyme of tetrahydrobiopterin biosynthesis from GTP, was observed in cerebellum, remaining brain, liver, spleen, and adrenal gland of rats treated with a single dose of lipopolysaccharide (LPS). This led to increased biopterin levels in tissues but not in plasma. Parallel induction of nitric oxide (NO) synthase was indicated by a 10- to 100-fold increase of plasma nitrate levels 6 and 12 hours after injection of LPS. Furthermore, systolic blood pressure was reduced significantly by 23%. Our results demonstrate induction of tetrahydrobiopterin biosynthesis after LPS treatment in vivo.
Assuntos
GTP Cicloidrolase/biossíntese , Lipopolissacarídeos/farmacologia , Animais , Biopterinas/análogos & derivados , Biopterinas/metabolismo , Pressão Sanguínea , Indução Enzimática , Masculino , Nitratos/sangue , Especificidade de Órgãos , Ratos , Ratos Sprague-DawleyRESUMO
It is known that the nucleus accumbens contains all elements of the nitric oxide (NO)-cyclic GMP (cGMP) system but the role of NO in this nucleus is not well understood. We investigated the contribution of the NO-cGMP system in the neurotransmission elicited by hippocampal nerve signals which are propagated to the nucleus accumbens via the fornix/fimbria. This glutamatergic hippocampus-accumbens projection was electrically stimulated for short periods in the urethane-anaesthetized rat. The nucleus accumbens was simultaneously superfused by the push-pull technique with compounds that influence the NO system and the released glutamate, aspartate and GABA were determined in the superfusate. Superfusion of the nucleus accumbens with the NO donor, PAPA/NO, enhanced basal release of the investigated amino acids with a complex concentration dependency. The release of glutamate and aspartate was also increased by the inhibitor of phosphodiesterase 5, UK-114,542. The PAPA/NO-elicited release of glutamate and aspartate was diminished by superfusion with the inhibitor of guanylyl cyclase, NS 2028. Basal release of amino acid transmitters was not influenced by NS 2028 and the NO synthase inhibitor, 7-NINA.Electrical stimulation of the fornix/fimbria increased the outflow of aspartate, glutamate and GABA in the nucleus accumbens. The stimulation-evoked release was abolished by superfusion of the nucleus with tetrodotoxin and strongly diminished by NS 2028, 7-NINA and N(G)-nitro-L-arginine methyl ester (L-name), while PAPA/NO facilitated stimulation-evoked release of these neurotransmitters. UK-114,542 also enhanced the evoked release of glutamate and aspartate while evoked GABA release was not influenced by the phosphodiesterase inhibitor. These findings indicate that NO plays the role of an excitatory transmitter in the nucleus accumbens and that nerve signals from the hippocampus propagated via fornix/fimbria induce NO synthesis in the nucleus accumbens. NO does not exert a tonic influence on basal release but facilitates release of aspartate, glutamate and GABA through increased cGMP synthesis. Phosphodiesterase 5 seems to be involved in the termination of the NO effect in glutamatergic but not in GABAergic neurons.
Assuntos
GMP Cíclico/metabolismo , Aminoácidos Excitatórios/metabolismo , Óxido Nítrico/metabolismo , Núcleo Accumbens/metabolismo , Diester Fosfórico Hidrolases/metabolismo , Ácido gama-Aminobutírico/metabolismo , 3',5'-GMP Cíclico Fosfodiesterases , Animais , Ácido Aspártico/metabolismo , Cateterismo , Nucleotídeo Cíclico Fosfodiesterase do Tipo 5 , Relação Dose-Resposta a Droga , Vias de Administração de Medicamentos , Estimulação Elétrica , Eletrodos Implantados , Inibidores Enzimáticos/farmacologia , Fórnice/fisiologia , Ácido Glutâmico/metabolismo , Masculino , Doadores de Óxido Nítrico/administração & dosagem , Doadores de Óxido Nítrico/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico Sintase Tipo I , Núcleo Accumbens/efeitos dos fármacos , Diester Fosfórico Hidrolases/efeitos dos fármacos , Ratos , Ratos Sprague-DawleyRESUMO
The aim of this study was to clarify the role of nitric oxide (NO) and lipid peroxidation (LPO) processes as well as the contribution of various neurotransmitters in pathophysiological mechanisms of neurotoxicity induced by amphetamine (AMPH). NO level was determined directly in brain tissues using electron paramagnetic resonance spectroscopy technique. The content of the products of lipid peroxidation (LPO) was measured spectrophotometrically as thiobarbituric acid reactive species (TBARS). The output of neurotransmitter amino acids (glutamate, aspartate, and GABA) and acetylcholine (ACH) was monitored in nucleus accumbens (NAc) by push-pull technique with HPLC detection. Repeated, systemic application of AMPH elevated striatal and cortical NO generation and LPO production. Moreover, administration of AMPH led to a marked and long-lasting increase of ACH release. Surprisingly, while glutamate output was not affected, aspartate release was enhanced 30 to 50 min after each AMPH injection. The release rate of GABA was also elevated. The selective NO-synthase inhibitor 7-nitroindazole (7-NI) was highly effective in abating the rise in the neurotransmitter release induced by the AMPH. The NOS inhibitor also abolished the increase of NO generation produced by AMPH, but did not influence the intensity of LPO elicited by the AMPH administration. Pretreatment with the noncompetitive NMDA receptor antagonist dizocilpine (MK-801) completely prevented increase of NO generation and TBARS formation induced by multiple doses of AMPH. Dizocilpine also abolished the effect of the psychostimulant drug on the release of neurotransmitters ACH, glutamate, aspartate, and GABA in the NAc. Our findings suggest a key role of NO in AMPH-induced transmitter release, but not in the formation of LPO products. It appears that AMPH enhances release of ACH and neurotransmitter amino acids through increased NO synthesis and induces neurotoxicity via NO and also by NO-independent LPO.
Assuntos
Acetilcolina/metabolismo , Aminoácidos/metabolismo , Anfetamina/toxicidade , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico/metabolismo , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Maleato de Dizocilpina/farmacologia , Indazóis/farmacologia , Masculino , Óxido Nítrico Sintase/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores de N-Metil-D-Aspartato/metabolismoRESUMO
We studied the possible role of neurotoxicity in the d,l-amphetamine (AMPH)-induced release of acetylcholine (ACH) in the nucleus accumbens (Nac) and the involvement of endogenous NO in this process. For determination of ACH release the Nac was superfused using the push-pull-technique. NO was directly measured using the electron paramagnetic resonance technique. Repeated administration of AMPH increased ACH release by about 400%. N-nitro-L-arginine (L-NNA) and 7-nitroindazole (7-NI) nearly abolished the AMPH-induced increase in ACH release. AMPH increased NO as well as lipid peroxidation (LPO) products in the cortex. L-NNA and 7-NI substantially diminished NO increase. AMPH-evoked LPO was only slightly reduced by these compounds. It is concluded that AMPH enhances ACH release through increased NO synthesis and induces neurotoxicity via NO and by LPO independent NO generation.
Assuntos
Acetilcolina/metabolismo , Anfetaminas/toxicidade , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico/metabolismo , Núcleo Accumbens/efeitos dos fármacos , Núcleo Accumbens/metabolismo , Anfetaminas/farmacologia , Animais , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Ratos , Ratos Sprague-DawleyRESUMO
Acetylcholine modulates histaminergic transmission via M(1) receptors. On the other hand, cholinergic transmission is modulated by neighbouring histaminergic neurons via H(1), H(2) and H(3) receptors. Dopaminergic and GABAergic neurons are also involved in these modulatory mechanisms. Furthermore, the release of histamine is modulated by glutamatergic neurons and nitric oxide of neuronal origin. The release of histamine in the brain oscillates according to circadian, slow ultradian and fast ultradian rhythms. Ultradian fluctuations have also been observed in the theta- and delta-frequency bands of the EEG spectral power. Simultaneous recordings of histamine outflow and EEG in the hypothalamus revealed that the ultradian histamine release rhythm coincides temporally with ultradian fluctuations in the EEG spectral power. Histamine receptor ligands used in pharmacotherapy, like H(1) and H(2) antagonists, modify the frequency of the EEG fluctuations. Brain histamine seems to be involved in memory processes, since inhibition of histamine synthesis deteriorates, while H(3) antagonists, histamine and histidine improve short-term memory. The latter finding may open new horizons in pharmacological treatment of memory disorders.
Assuntos
Encéfalo/fisiologia , Histamina/fisiologia , Memória/fisiologia , Atividade Motora/fisiologia , Ciclos de Atividade/fisiologia , Animais , Ritmo Circadiano/fisiologia , Eletroencefalografia , Humanos , Neurônios/fisiologia , Óxido Nítrico/fisiologia , Receptores Histamínicos/fisiologia , Fases do Sono/fisiologiaRESUMO
Mutual modulatory and functional interactions exist between the histaminergic and cholinergic systems in the brain. The activity of histaminergic neurons is permanently modulated by neighboring cholinergic neurons via muscarinic M(1) receptors, cholinergic transmission by histaminergic neurons through H(1), H(2), H(3A) and H(3B) receptors. In the nucleus accumbens, glutamatergic neurons originating from the hippocampus modulate cholinergic transmission in a direct way via stimulation of NMDA receptors located on cholinergic neurons. Additionally, glutamatergic neurons of the hippocampus modulate the activity of cholinergic neurons in an indirect way by stimulating histaminergic neurons within the nucleus accumbens. Reciprocal regulatory influences and neurotransmission are subjected to the global modulatory influence of nitric oxide. Both histaminergic and cholinergic systems in the nucleus accumbens are implicated in the response to aversive stimuli. Memory acquisition is associated with activation of cholinergic transmission in the nucleus accumbens, while stimulation of histaminergic neurons facilitates memory in a way that is independent of the cholinergic system. Hence, both histaminergic and cholinergic transmission within the nucleus accumbens and interactions between the two systems seem to play a predominant role in cognition.
RESUMO
The social memory test was used so as to investigate whether brain histamine is involved in short-term memory. Histamine injected intracerebroventricularly (i.c.v.) decreased investigation time of a juvenile rat by an adult rat. A similar effect was elicited by i.c.v. administration of histidine. Compared with the control animals, rat pretreatment with alpha-fluoromethylhistidine (FMH), which inhibits neuronal synthesis of histamine, prolonged recognition time. The H3-receptor agonist immepip also prolonged investigation time, while the H3-antagonist thioperamide exerted the opposite effect. Treatment with histidine increased, while treatment with FMH decreased histamine levels in various brain regions. It is concluded that histamine released from histaminergic neurons facilitates short-term memory.
Assuntos
Comportamento Animal/fisiologia , Histamina/fisiologia , Memória de Curto Prazo/fisiologia , Neurônios/fisiologia , Comportamento Social , Animais , Comportamento Animal/efeitos dos fármacos , Agonistas dos Receptores Histamínicos/farmacologia , Antagonistas dos Receptores Histamínicos/farmacologia , Histidina/farmacologia , Imidazóis/farmacologia , Masculino , Metilistidinas/farmacologia , Piperidinas/farmacologia , Ratos , Ratos Sprague-Dawley , Fatores de TempoRESUMO
In conscious rats, the basal forebrain was superfused through a push-pull cannula and the release of acetylcholine was determined in the superfusate. Superfusion with the nitric oxide (NO) synthase inhibitor, NG-nitro-L-arginine, diminished the release of acetylcholine. Subsequent superfusion with the NO donor, 3-morpholino-sydnonimine, enhanced the release of the neurotransmitter. It is concluded that endogenous NO enhances the release of acetylcholine from its neurons.
Assuntos
Acetilcolina/metabolismo , Óxido Nítrico/metabolismo , Prosencéfalo/efeitos dos fármacos , Aminoácido Oxirredutases/antagonistas & inibidores , Animais , Arginina/análogos & derivados , Arginina/farmacologia , Molsidomina/análogos & derivados , Molsidomina/farmacologia , Óxido Nítrico Sintase , Nitroarginina , Prosencéfalo/metabolismo , RatosRESUMO
The influence of nitric oxide (NO) on adenosine release was investigated by the push-pull technique in the ventral striatum of the urethane-anaesthetized rat. Superfusion with the NO donor diethylamine-NO enhanced, whereas superfusion with the NO synthase inhibitor L-NG-nitroarginine methyl ester decreased the output of adenosine. The effect of L-NG-nitroarginine methyl ester was abolished by L-arginine methyl ester. These findings indicate that, in the ventral striatum of the rat, NO modulates adenosine release.
Assuntos
Adenosina/metabolismo , Corpo Estriado/metabolismo , Óxido Nítrico/fisiologia , Animais , Arginina/análogos & derivados , Arginina/farmacologia , Masculino , Nitroarginina , Ratos , Ratos Sprague-DawleyRESUMO
The olfactory social memory test, based on the recognition of a juvenile rat by a male adult rat, was used to investigate whether melatonin influences memory. Intracerebroventricular (i.c.v.) injection of 1.1 nmol melatonin shortened recognition time, while the melatonin ML1 receptor antagonist luzindole (1 nmol) exerted the opposite effect. The facilitating influence of melatonin was abolished in the presence of 0.5 nmol luzindole. The findings suggest that endogenous melatonin facilitates short-term memory.
Assuntos
Melatonina/farmacologia , Memória/efeitos dos fármacos , Animais , Injeções Intraventriculares , Masculino , Ratos , Ratos Sprague-Dawley , Receptores de Superfície Celular/efeitos dos fármacos , Receptores Citoplasmáticos e Nucleares/efeitos dos fármacos , Receptores de Melatonina , Comportamento Social , Triptaminas/farmacologiaRESUMO
The delta and theta frequency bands of the EEG in the posterior hypothalamic area (PH) of the urethane-anaesthetized rat vary according to an ultradian rhythm with a frequency of approximately one cycle per 100 min. Injected into the lateral ventricle, prazosin (150 nmol) abolished the rhythmic changes, propranolol (150 nmol) increased, while yohimbine, SKF-83566 and sulpiride (150 nmol each) decreased the cycle duration. Electrocoagulation of the rostral arcuate nucleus and median eminence (Arc-ME) of medial basal hypothalamus abolished the rhythmic EEG changes in the PH. Our results indicate that the ultradian EEG rhythm in the PH is susceptible to regulatory influences mediated by noradrenergic and dopaminergic neurons. For the generation of the ultradian rhythm, the functional integrity of the Arc-ME is required.
Assuntos
Ritmo Circadiano/fisiologia , Hipotálamo/fisiologia , Animais , Eletroencefalografia , Masculino , Prazosina/farmacologia , Propranolol/farmacologia , Ratos , Ratos Sprague-Dawley , Sulpirida/farmacologia , Fatores de Tempo , Ioimbina/farmacologiaRESUMO
The delta and theta frequency bands of the electroencephalogram (EEG) in the posterior hypothalamic area (PH) of rats vary according to an ultradian rhythm with a frequency of approximately 1 cycle/100 min. The influence of histamine-related drugs on the ultradian hypothalamic EEG rhythm was now studied in urethane anaesthetized rats. Injected into the lateral ventricle, metoprine (inhibitor of histamine catabolism) and alpha-fluoromethylhistidine (inhibitor of histamine synthesis) did not alter the duration of the rhythmic changes. The H1 receptor agonist 2-(2-aminoethyl)-thiazole was ineffective, while mepyramine (H1 receptor antagonist) prolonged the cycle duration of delta and theta frequency bands. Stimulation of H2 and H3 receptors by amthamine and immepip, respectively, also prolonged the cycle duration of these frequency bands, while the H2 antagonist famotidine and the H3 antagonist thioperamide exerted the opposite effects. Our results indicate that the ultradian EEG rhythm in the PH is susceptible to regulatory influences mediated by the histaminergic system of the brain.
Assuntos
Ciclos de Atividade/efeitos dos fármacos , Eletroencefalografia/efeitos dos fármacos , Agonistas dos Receptores Histamínicos/farmacologia , Antagonistas dos Receptores Histamínicos/farmacologia , Hipotálamo Posterior/efeitos dos fármacos , Hipotálamo Posterior/fisiologia , Animais , Ritmo Delta/efeitos dos fármacos , Histamina/biossíntese , Concentração de Íons de Hidrogênio , Masculino , Ratos , Ratos Sprague-Dawley , Ritmo Teta/efeitos dos fármacosRESUMO
The EEG signal of the area hypothalami posterior (PH) was recorded in the urethane anaesthetized rat. The main characteristic of the EEG in this brain region was intermittent oscillations of high amplitude in the delta and theta frequency bands. Oscillations of the alpha and beta frequency bands showed comparatively lower variations. Time distribution analysis of the EEG spectral power revealed that the delta and theta rhythms appeared and disappeared according to an ultradian rhythm with a frequency of approximately 1 cycle per 100 min. No significant rhythm was found in the alpha and beta band. The rhythm frequency of neuronal activity in the PH is very similar to the ultradian frequency of pulsatile neurotransmitter release in the PH demonstrated previously.
Assuntos
Ciclos de Atividade , Ritmo Delta , Hipotálamo Posterior/fisiologia , Ritmo Teta , Animais , Masculino , Oscilometria , Ratos , Ratos Sprague-DawleyRESUMO
In order to study whether Alzheimer-like neuropathological changes involve the central histaminergic system we measured the concentration of histamine, its precursor histidine as well as the activity of histidine decarboxylase (HDC) and histamine-N-methyl-transferase (HMT) in frontal cortex of aging Down syndrome (DS) patients, Alzheimer patients and control individuals. The study populations were also investigated for choline acetyltransferase (ChAT) activity, since reduced ChAT activity is an established biochemical hallmark in DS and Alzheimer disease (AD). HDC and ChAT activity were reduced in brains of both DS and Alzheimer patients versus control patients. Additionally, we observed a significant decrease of histamine levels in the DS group. Histamine levels in AD brains tended to be decreased. Histidine concentrations and HMT activities were comparable between the three groups. Thus, our results for the first time show histaminergic deficits in brains of patients with DS resembling the neurochemical pattern in AD. Neuropathological changes may be responsible for similar neurochemical alterations of the histaminergic system in both dementing disorders.
Assuntos
Envelhecimento/metabolismo , Doença de Alzheimer/metabolismo , Encéfalo/metabolismo , Síndrome de Down/metabolismo , Histamina/metabolismo , Idoso , Envelhecimento/patologia , Doença de Alzheimer/patologia , Encéfalo/patologia , Estudos de Casos e Controles , Síndrome de Down/patologia , Feminino , Lobo Frontal/metabolismo , Histamina N-Metiltransferase/metabolismo , Histidina/metabolismo , Histidina Descarboxilase/metabolismo , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Histaminergic neurons of the brain have been implicated in genetic hypertension. We investigated the effect of inhibition of histamine synthesis by alpha-fluoromethylhistidine (alpha-FMH), the irreversible inhibitor of histidine decarboxylase, on the development and maintenance of hypertension in spontaneously hypertensive rats. Young (3-week-old) and adult (7-week-old) rats were treated with alpha-fluoromethylhistidine for 29 and 13 days, respectively. Treatment of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats with alpha-fluoromethylhistidine led to a pronounced decrease in the histidine decarboxylase activity and in the histamine concentration in the brain (hypothalamus, brainstem, cortex-midbrain). In adult spontaneously hypertensive rats, the development of hypertension was not influenced by alpha-fluoromethylhistidine. In young spontaneously hypertensive rats, alpha-fluoromethylhistidine led to a transient delay in the development of hypertension which was followed by a transient tendency to increased blood pressure. It is concluded that histaminergic neurons of the brain play only a subordinate role, if any at all, in the development of hypertension in spontaneously hypertensive rats.
Assuntos
Encéfalo/metabolismo , Histamina/biossíntese , Hipertensão/etiologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Química Encefálica , Tronco Encefálico/metabolismo , Córtex Cerebral/metabolismo , Histamina/fisiologia , Histidina Descarboxilase/antagonistas & inibidores , Histidina Descarboxilase/metabolismo , Hipotálamo/metabolismo , Mesencéfalo/metabolismo , Metilistidinas/farmacologia , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKYRESUMO
The release of endogenous acetylcholine was investigated by the push-pull technique. The posterior hypothalamus of conscious rats was superfused through a push-pull cannula with artificial cerebrospinal fluid (ACSF) which contained 1 mumol/l neostigmine. Acetylcholine was determined in the superfusate by high pressure liquid chromatography and electrochemical detection. Hypothalamic superfusion with potassium-rich (100 mmol/l) ACSF led to a pronounced increase in the release rate of acetylcholine. Tetrodotoxin (1 mumol/l) almost abolished the basal release of the neurotransmitter. Superfusion of the hypothalamus with atropine (10 or 50 mumol/l) led to a concentration-dependent increase, whereas superfusion with oxotremorine (50 mumol/l) inhibited the release rate of acetylcholine. It is concluded that acetylcholine released into the superfusate of the hypothalamus originates from cholinergic neurons. Furthermore, the release of acetylcholine seems to be modulated by muscarinic acetylcholine receptors, probably located on cholinergic neurons of the hypothalamus.
Assuntos
Acetilcolina/metabolismo , Hipotálamo/metabolismo , Animais , Atropina/farmacologia , Cateterismo , Masculino , Oxotremorina/farmacologia , Potássio/farmacologia , Ratos , Ratos Endogâmicos , Tetrodotoxina/farmacologiaRESUMO
The modulation of the histamine release from histaminergic neurons by noradrenergic neurons was investigated by the push-pull technique. The posterior hypothalamus of the conscious, freely moving rat was superfused with artificial CSF through a push-pull cannula and the release of endogenous histamine was determined in the superfusate. Hypothalamic superfusion with a potassium-rich CSF enhanced the release rate of histamine. Superfusion with the alpha 2-agonists noradrenaline or clonidine diminished the release rate of histamine. Moreover, clonidine abolished the potassium-induced increase in the histamine release. Superfusion with the alpha 2-antagonists yohimbine or idazoxan enhanced the release rate of histamine. It is concluded that noradrenaline released from noradrenergic neurons of the hypothalamus modulates the release of histamine from histaminergic neurons by stimulating alpha 2-adrenoreceptors located on histaminergic nerve terminals.
Assuntos
Agonistas alfa-Adrenérgicos/farmacologia , Antagonistas Adrenérgicos alfa/farmacologia , Liberação de Histamina/efeitos dos fármacos , Hipotálamo/efeitos dos fármacos , Animais , Clonidina/farmacologia , Dioxanos/farmacologia , Hipotálamo/metabolismo , Idazoxano , Masculino , Norepinefrina/metabolismo , Norepinefrina/farmacologia , Ratos , Ratos Endogâmicos , Ioimbina/farmacologiaRESUMO
The mamillary body and the medial amygdaloid nucleus of cats anaesthetized with sodium pentobarbital were bilaterally and simultaneously superfused through push-pull cannulae with CSF and the release of endogenous histamine was determined in the superfusates. Collection of the superfusates in 10 min time periods revealed that histamine was rhythmically released in the two areas with frequencies of one cycle/90 min (mamillary body) or one cycle/135 min (medial amygdaloid nucleus). Collection of the superfusates in time periods of 2 min revealed the existence of an additional ultradian rhythm with a frequency of approximately one cycle/19 min in both areas. Bilateral lesions of the suprachiasmatic nucleus did not seem to influence the pattern of histamine release in the mamillary body and the medial amygdaloid nucleus, but the rate of histamine release was decreased in the mamillary body. It is concluded that the ultradian rhythms of histamine release in the mamillary body and the medial amygdaloid nucleus are not dependent on the integrity of the suprachiasmatic nucleus. The rate of histamine release in the mamillary body seems to be under the influence of excitatory neurons which originate from the suprachiasmatic nucleus.